---

---

tags : Pharm-country   

save search

---

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
LUCD | $0.785 -2.13% 64K |

| -14.72% | O: -0.87% H: 0.55% C: -2.14%
PAVM | $1.97 10K |

Health Technology

| -10.45% | O: -1.36% H: 1.38% C: -0.92%
conference diagnostics

---

BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
Published: 2024-04-08 (Crawled : 12:00) - biospace.com/
BCLI | $0.497 -8.1% 770K |

Health Technology

| -21.62% | O: -0.37% H: 0.0% C: 0.0%
update cell nurown program therapeutics

---

Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
COR | $236.11 -1.05% 630K |

Finance

| -1.56% | O: 0.28% H: 0.45% C: 0.21%
for

---

iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency in the U.S.
Published: 2024-04-04 (Crawled : 23:00) - biospace.com/
DTIL | $11.4 -0.96% 45K |

Health Technology

| -16.65% | O: -2.33% H: 1.64% C: -4.91%
ecur-506 fda drug treatment clearance for application trial

---

Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
CTXR | $0.896 9.78% 4.5M |

Health Technology

| -22.29% | O: -0.51% H: 3.13% C: -1.23%
conference pharmaceuticals

---

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
BDX | $230.84 -0.59% 300K |

Health Technology

| -5.16% | O: 0.61% H: 0.0% C: 0.0%
ANGO | $6.155 -2.77% 190K |

Health Technology

| 3.17% | O: 1.43% H: 12.5% C: 0.0%
year financial

---

Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
RVMD S | $36.9 0.22% 250K |

Health Technology

| 17.3% | O: 0.67% H: 1.8% C: -4.62%
antibody collaboration therapeutics

---

Immunic to Host MS R&D Day and Participate in Investor Conferences in April 2024
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
IMUX | $1.27 4.96% 200K |

Health Technology

| -0.82% | O: 0.0% H: 3.28% C: 0.82%
day

---

Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.
Published: 2024-04-04 (Crawled : 11:00) - biospace.com/
HSIC | $69.64 -0.8% 360K |

Distribution Services

| -4.22% | O: 0.86% H: 0.14% C: -1.39%
acquisition

---

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeCompany’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
AMRN | News | $0.9 -1.87% 590K |

Health Technology

| -6.16% | O: 3.03% H: 8.82% C: 3.92%
vazkepa europe update

---

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals
Published: 2024-04-03 (Crawled : 13:00) - biospace.com/
URGN | $14.37 0.91% 170K |

Health Technology

| 3.97% | O: -0.64% H: 0.71% C: -2.43%
pharma patent pharmaceuticals teva

---

electroCore Expands Intellectual Property PortfolioelectroCore Granted Two New U.S. Patents
Published: 2024-04-02 (Crawled : 23:00) - biospace.com/
ECOR | $5.75 2.95% 4.6K |

Health Technology

| -9.97% | O: -1.63% H: 0.0% C: -2.16%
granted

---

Traws Pharma Announces New Employee Inducement Grants - April 02, 2024
Published: 2024-04-02 (Crawled : 13:00) - biospace.com/
ONTX | $0.9953 -5.61% 1.3M |

Health Technology

| Email alert Add to watchlist
pharma grants employee

---

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
Published: 2024-04-02 (Crawled : 11:00) - biospace.com/
RCKT M | $23.61 -0.3% 94K |

Health Technology

| -11.21% | O: -1.76% H: 0.0% C: -1.91%
anemia authorization treatment pharmaceuticals application

---

Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
INCY | $52.59 -0.25% 880K |

Health Technology

| -8.02% | O: -0.6% H: 0.0% C: -0.58%
license collaboration asia agreement

---

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP | News 0 d | $3.065 -26.67% 690K |

Manufacturing

| 785.78% | O: 895.97% H: 14.34% C: 11.7%
business year update pharmaceuticals financial results

---

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
SBFM | $3.205 -15.66% 1.9M |

Professional, Scientific, and T...

| 11139.67% | O: 83.97% H: 18.6% C: -4.31%
year biopharma results

---

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.23 13K |

Health Technology

| -17.45% | O: 5.37% H: 0.64% C: -12.1%
obesity treatment wholly

---

Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
AMRX | $5.345 -2.11% 310K |

Health Technology

| -10.21% | O: 0.0% H: 0.33% C: -2.64%
fda approval

---

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
AVXL | $3.955 -2.83% 740K |

Health Technology

| -11.59% | O: 0.0% H: 1.07% C: -2.36%
conference life sciences anavex

---

Gainers vs Losers

72%

28%

Top 10 Gainers

AGBA | $1.05 162.5% 100M |

Finance

ISPC | $0.4621 116.95% 15M |

Professional, Scientific, and T...

INVO | $1.515 99.34% 4.3M |

Health Technology

BPTH | $5.62 73.46% 75M |

Health Technology

TIRX | $0.8231 69.78% 54M |

SINT | $0.0519 39.14% 350M |

Health Technology

XPON | $2.63 36.27% 8.4M |

VTNR S | $1.26 28.68% 9.1M |

Industrial Services

SWVL | $9.64 27.35% 200K |

n/a

DFLI A | $0.7726 25.52% 4.3M |

---

Your saved searches

---